 |
Nanocomplex consisting of a small interfering RNA that targets the human EV11 oncogenic transcription factor and an elastin-like polypeptide drug carrier. |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-05-23 00:00:00 |
| Sponsor | PeptiMed;922 Walsh Road, Suite 208;Madison, Wisconsin, 53714 |
